Immune checkpoint blockade therapy for esophageal squamous cell carcinoma.

about

Immune checkpoint blockade therapy for esophageal squamous cell carcinoma.

Item

http://www.wikidata.org/entity/Q54968549

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Immune checkpoint blockade therapy for esophageal squamous cell carcinoma.

@en

Immune checkpoint blockade therapy for esophageal squamous cell carcinoma.

@nl

type

Item

label

Immune checkpoint blockade therapy for esophageal squamous cell carcinoma.

@en

Immune checkpoint blockade therapy for esophageal squamous cell carcinoma.

@nl

prefLabel

Immune checkpoint blockade therapy for esophageal squamous cell carcinoma.

@en

Immune checkpoint blockade therapy for esophageal squamous cell carcinoma.

@nl

P1476

Immune checkpoint blockade therapy for esophageal squamous cell carcinoma

@en

P2093

Dilsa Mizrak Kaya

http://www.w3.org/2001/XMLSchema#string

Hideo Baba

http://www.w3.org/2001/XMLSchema#string

Kazuto Harada

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Signatures of mutational processes in human cancer

B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.

Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Classifying Cancers Based on T-cell Infiltration and PD-L1.

Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses.

Clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with esophageal squamous cell carcinoma: a meta-analysis.

Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy.

P304

699-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/JTD.2018.01.120

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jaffer Ajani

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29607137

http://www.w3.org/2001/XMLSchema#string

P932

5864622

http://www.w3.org/2001/XMLSchema#string